Form 4: O'Connor Acquires Shares of LeMaitre Vascular Through Performance Share Unit Settlement

Sentiment:

SEC Form 4 Filing


John James O'Connor, a director at LeMaitre Vascular, acquired shares of common stock through the settlement of a Performance Share Unit (PSU) award and release of dividend equivalent rights.

Summary

  • On February 29, 2024, John James O'Connor, a director of LeMaitre Vascular, Inc. (LMAT), acquired 593 shares of common stock upon the settlement of a Performance Share Unit (PSU) award.
  • The PSU award was granted on December 12, 2022, and vests in installments.
  • O'Connor also acquired 1 share upon the release of dividend equivalent rights.
  • Following these transactions, O'Connor directly owns 57,563 shares of LMAT common stock.
  • The transactions were reported on Form 4, filed with the SEC on March 4, 2024.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting insider transactions, which is neutral in sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.

Stakeholder Impact

  • The transaction has a minimal impact on stakeholders as it represents a small change in ownership by a company director.

Key Dates

DateDescription
2022/12/12Date of grant for Performance Share Unit (PSU) award.
2024/02/29Date of transaction: Acquisition of shares through PSU settlement and release of dividend equivalent rights.
2024/03/04Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.